Skip to main content

Table 3 Compilation of available data on 35 cases of daptomycin-induced eosinophilic pneumonia

From: Daptomycin-induced eosinophilic pneumonia - a systematic review

Sex, n (%)

Male

29 (83)

Female

6 (17)

Age(years), mean ± SD

65.4 ± 15

Daptomycin indication, n (%)

Osteomyelitis/diabetic foot infection

11 (31)

Prosthetic joint infection

9 (26)

Endocarditis

5 (14)

Bacteremia

4 (11)

Abscess

3 (9)

Other

3 (9)

Daptomycin dose (mg/kg/day), mean ± SD

6.4 ± 1.6

Treatment duration at symptom onset (weeks), mean ± SD

2.8 ± 1.6

Clinical findings, n (%)

Dyspnea

33 (94)

Fever

20 (57)

Cough

13 (37)

Requiring oxygen

15 (43)

Requiring mechanical ventilation

12 (34)

Infiltrates/opacities of CT/CXR, n (%)

30 (86)

BAL eosinophils %, mean ± SD

32 ± 22.4

Peripheral eosinophilia, n (%)

27 (77)

Lung biopsy consistent with AEP, n (%)

6 (17)

Treatment, n (%)

Daptomycin discontinued only

12 (34)

Daptomycin discontinued plus corticosteroid

23 (66)

  1. AEP acute eosinophilic pneumonia, BAL bronchoalveolar lavage, CT computed tomography, CXR chest x-ray, SD standard deviation